Benzinga - by Lisa Levin, Benzinga Editor.
- Goldman Sachs increased the price target for Constellation Brands, Inc. (NYSE: STZ) from $275 to $305. Goldman Sachs analyst Bonnie Herzog maintained a Buy rating. Constellation shares fell 0.8% to $254.00 in pre-market trading.
- Wedbush raised CarMax, Inc. (NYSE: KMX) price target from $85 to $90. Wedbush analyst Seth Basham upgraded the stock from Neutral to Outperform. CarMax shares fell 2.8% to close at $76.66 on Friday.
- Raymond James slashed the price target for Allegiant Travel Company (NASDAQ: ALGT) from $145 to $118. Raymond James analyst Savanthi Syth maintained an Outperform rating. Allegiant Travel shares fell 2.4% to close at $75.32 on Friday.
- HC Wainwright & Co. lowered the price target for AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) from $8 to $5. Ca HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. AcelRx Pharmaceuticals shares fell 8.3% to $0.6149 in pre-market trading.
- Jefferies lowered Urban Outfitters, Inc. (NASDAQ: URBN) price target from $42 to $31. Jefferies analyst Randal Konik downgraded the stock from Buy to Hold. Urban Outfitters shares fell 4.1% to $30.60 in pre-market trading.
- Morgan Stanley slashed Vaccitech plc (NASDAQ: VAC) price target from $14 to $3.25. Morgan Stanley analyst Matthew Harrison downgraded the stock from Overweight to Equal-Weight. Vaccitech shares fell 1.2% to close at $1.66 on Friday.
- Bernstein boosted Baidu, Inc. (NASDAQ: BIDU) price target from $160 to $168. Bernstein analyst Boris Van maintained an Outperform rating. Baidu shares fell 1.7% to $130.10 in pre-market trading.
- Jefferies cut NIKE, Inc. (NYSE: NKE) price target from $140 to $100. Jefferies analyst Randal Konik downgraded the stock from Buy to Hold. NIKE shares fell 1.6% to $89.39 in pre-market trading.
- Deutsche Bank boosted the price target for Dell Technologies Inc. (NYSE: DELL) from $68 to $75. Deutsche Bank analyst Sidney Ho maintained a Buy rating. Dell shares fell 0.1% to $69.99 in pre-market trading.
- Jefferies increased AstraZeneca PLC (NASDAQ: AZN) price target from $66.5 to $80. Jefferies analyst Peter Welford upgraded the stock from Hold to Buy. AstraZeneca shares rose 1.4% to $68.77 in pre-market trading.
- Truist Securities raised Mastercard Incorporated (NYSE: MA) price target from $450 to $475. Truist Securities analyst Andrew Jeffrey maintained a Buy rating. Mastercard shares fell 0.3% to $401.01 in pre-market trading.
Check This Out: United Natural Foods Likely To Post Q4 Loss; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.